These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30248785)

  • 21. Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease.
    Erer B; Takeuchi M; Ustek D; Tugal-Tutkun I; Seyahi E; Özyazgan Y; Duymaz-Tozkir J; Gül A; Kastner DL; Remmers EF; Ombrello MJ
    Genes Immun; 2016 Dec; 17(7):396-399. PubMed ID: 27708262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif.
    Eller MA; Koehler RN; Kijak GH; Eller LA; Guwatudde D; Marovich MA; Michael NL; de Souza MS; Wabwire-Mangen F; Robb ML; Currier JR; Sandberg JK
    J Virol; 2011 May; 85(10):4802-11. PubMed ID: 21411516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.
    Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ
    J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing.
    Carlomagno S; Falco M; Bono M; Alicata C; Garbarino L; Mazzocco M; Moretta L; Moretta A; Sivori S
    Front Immunol; 2017; 8():581. PubMed ID: 28603523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-Bw4-B*57 and Cw*18 alleles are associated with plasma viral load modulation in HIV-1 infected individuals in Salvador, Brazil.
    Silva EM; Acosta AX; Santos EJ; Netto EM; Lemaire DC; Oliveira AS; Barbosa CM; Bendicho MT; Galvão-Castro B; Brites C
    Braz J Infect Dis; 2010; 14(5):468-75. PubMed ID: 21221475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis.
    Díaz-Peña R; Vidal-Castiñeira JR; Alonso-Arias R; Suarez-Alvarez B; Vicario JL; Solana R; Collantes E; López-Vázquez A; Martínez-Borra J; López-Larrea C
    Arthritis Rheum; 2010 Apr; 62(4):1000-6. PubMed ID: 20131260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1.
    Alicata C; Pende D; Meazza R; Canevali P; Loiacono F; Bertaina A; Locatelli F; Nemat-Gorgani N; Guethlein LA; Parham P; Moretta L; Moretta A; Bottino C; Norman PJ; Falco M
    Eur J Immunol; 2016 Jun; 46(6):1511-7. PubMed ID: 26990677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals.
    Guerini FR; Lo Caputo S; Gori A; Bandera A; Mazzotta F; Uglietti A; Zanzottera M; Maserati R; Clerici M
    J Infect Dis; 2011 May; 203(9):1235-9. PubMed ID: 21398398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the KIR3DS1/Bw4 distribution in Chinese healthy and acute myeloid leukemia individuals.
    Tao S; He Y; Zhang W; Wang W; He J; Han Z; Chen N; Dong L; He J; Zhu F; Lv H
    Hum Immunol; 2015 Mar; 76(2-3):79-82. PubMed ID: 25636577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Copy number variation of KIR genes influences HIV-1 control.
    Pelak K; Need AC; Fellay J; Shianna KV; Feng S; Urban TJ; Ge D; De Luca A; Martinez-Picado J; Wolinsky SM; Martinson JJ; Jamieson BD; Bream JH; Martin MP; Borrow P; Letvin NL; McMichael AJ; Haynes BF; Telenti A; Carrington M; Goldstein DB; Alter G;
    PLoS Biol; 2011 Nov; 9(11):e1001208. PubMed ID: 22140359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection.
    Boulet S; Kleyman M; Kim JY; Kamya P; Sharafi S; Simic N; Bruneau J; Routy JP; Tsoukas CM; Bernard NF
    AIDS; 2008 Jul; 22(12):1487-91. PubMed ID: 18614872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.
    Mulrooney TJ; Zhang AC; Goldgur Y; Boudreau JE; Hsu KC
    J Immunol; 2015 Aug; 195(3):1242-50. PubMed ID: 26109640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals.
    Boulet S; Sharafi S; Simic N; Bruneau J; Routy JP; Tsoukas CM; Bernard NF
    AIDS; 2008 Mar; 22(5):595-9. PubMed ID: 18317000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2.
    Long BR; Erickson AE; Chapman JM; Barbour JD; Vu BA; Ho EL; Lanier LL; Sauer MM; Carvalho KI; Nixon DF; Kallas EG
    Immunology; 2010 Feb; 129(2):186-96. PubMed ID: 19824915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.
    Kamya P; Boulet S; Tsoukas CM; Routy JP; Thomas R; Côté P; Boulassel MR; Baril JG; Kovacs C; Migueles SA; Connors M; Suscovich TJ; Brander C; Tremblay CL; Bernard N;
    J Virol; 2011 Jun; 85(12):5949-60. PubMed ID: 21471235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human leukocyte antigen Bw4 and Bw6 epitopes recognized by antibodies and natural killer cells.
    Lutz CT
    Curr Opin Organ Transplant; 2014 Aug; 19(4):436-41. PubMed ID: 24977435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope.
    Saunders PM; Vivian JP; Baschuk N; Beddoe T; Widjaja J; O'Connor GM; Hitchen C; Pymm P; Andrews DM; Gras S; McVicar DW; Rossjohn J; Brooks AG
    J Immunol; 2015 Jan; 194(2):781-789. PubMed ID: 25480565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1.
    O'Connor GM; Yamada E; Rampersaud A; Thomas R; Carrington M; McVicar DW
    J Immunol; 2011 Sep; 187(5):2162-71. PubMed ID: 21804024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes.
    Gillespie GM; Bashirova A; Dong T; McVicar DW; Rowland-Jones SL; Carrington M
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):451-5. PubMed ID: 17411378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.